Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1991-11-18
|
pubmed:abstractText |
The prevalence of antibody to hepatitis C virus (HCV) was estimated in 3 tropical populations using 2 screening ELISAs to detect antibody to the c100-3 antigen and 2 supplementary assays designed to test the specificity of these tests. Two hundred and eighty-six of 385 (74.2%) sera from Kiribati, 17 of 138 (12.3%) sera from Vanuatu, and 39 of 173 (22.5%) sera from Zaire were reactive in the initial screening assay. The proportion of reactive sera which were also reactive in the second screening ELISA varied between populations (55.1% in Kiribati, 85.1% in Vanuatu, and 39.2% from Zaire). Reactive sera were selected at random for confirmatory testing. Only 3 of 49 (6.12%) of sera from Kiribati and 1 of 14 (4.76%) of sera from Vanuatu positive in the initial ELISA were reactive in the confirmatory assays. The proportion of confirmed positive sera from Zaire was higher 8 of 28 (28.5%). Based on the results of these supplementary assays the estimated prevalence of anti-HCV in these populations is 4.8% in Kiribati, less than 1% in Vanuatu, and 6.4% in Zaire. Reliance on a single screening ELISA to estimate the prevalence of anti-HCV in stored sera from tropical communities may lead to a gross over-estimate of the true prevalence in these populations.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0146-6615
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
143-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1919536-Antibody Specificity,
pubmed-meshheading:1919536-Democratic Republic of the Congo,
pubmed-meshheading:1919536-Dengue,
pubmed-meshheading:1919536-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:1919536-Female,
pubmed-meshheading:1919536-Hepatitis Antibodies,
pubmed-meshheading:1919536-Hepatitis B,
pubmed-meshheading:1919536-Hepatitis B Surface Antigens,
pubmed-meshheading:1919536-Hepatitis C,
pubmed-meshheading:1919536-Humans,
pubmed-meshheading:1919536-Male,
pubmed-meshheading:1919536-Prevalence,
pubmed-meshheading:1919536-Vanuatu
|
pubmed:year |
1991
|
pubmed:articleTitle |
Prevalence of hepatitis C in tropical communities: the importance of confirmatory assays.
|
pubmed:affiliation |
Department of Virology, United Medical School, Guy's Hospital, London, England.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|